Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Endoplasmic Reticulum (ER) stress-induced apoptosis regulatory machinery is a complex signaling network, primarily mediated by the Unfolded Protein Response (UPR), that dictates cell fate under conditions of proteotoxic stress (PubMed: 17276491). This machinery is governed by three principal transmembrane sensors: PERK (EIF2AK3), IRE1α (ERN1), and ATF6, which monitor the protein-folding environment within the ER lumen (UniProt: Q9NZJ5, O75460, P18850). While the initial response is adaptive—aimed at restoring homeostasis by reducing protein synthesis and increasing chaperone activity—prolonged or severe stress triggers a switch to a pro-apoptotic program. This transition is characterized by the upregulation of the transcription factor CHOP (DDIT3) and the activation of downstream effectors such as JNK and Caspase-12 (or Caspase-4 in humans) (PubMed: 18948566). Dysregulation of this machinery is a hallmark of numerous pathologies, including neurodegenerative diseases like Alzheimer's, where misfolded protein aggregates overwhelm the ER, and various cancers, where the UPR is exploited to survive metabolic stress (PubMed: 21407240, 25435150). Consequently, this machinery is a significant therapeutic target, with pharmacological strategies focusing on chemical chaperones like 4-phenylbutyric acid to alleviate stress or small-molecule inhibitors like KIRA6 and GSK2606414 to modulate specific UPR branches (PubMed: 24813844).
The machinery functions by sensing ER lumenal stress and transducing signals through the PERK, IRE1, and ATF6 pathways to either attenuate protein translation and increase folding capacity or, if stress persists, activate pro-apoptotic factors like CHOP and caspases.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum stress-induced apoptosis regulatory machinery (UPR).